fah hospital policy blog

Perspectives on health policy affecting America’s hospitals and the patients we serve.

Category Archives: pharmaceuticals

FAH, 45 Other Groups Urge Senators to Pass CREATES Act

June 07, 2018 | FAH Policy Blog Team

Category: FAH News, Legislation, Medicare, Pharmaceuticals

A wide ranging coalition of 46 groups, that include FAH, from across the health care spectrum sent a letter today to leaders of the Senate Judiciary Committee urging swift action on the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974).

Read More »

FAH Highlights to Congress Effective Ways to Combat Opioid Epidemic

March 16, 2018 | FAH Policy Blog Team

Category: Legislation, Pharmaceuticals

FAH sent a letter today to leaders on the House Ways and Means Committee highlighting policy changes that would help in battling the opioid epidemic.

Reps. Kevin Brady (R-TX), Richard Neal (D-MA), Peter Roskam (R-IL) and Sander Levin (D-MI) recently asked stakeholders to share their thoughts on ways to fight the crisis.

Read More »

Campaign for Sustainable Rx Pricing Urges House to Pass CREATES Act

September 19, 2017 | FAH Policy Blog Team

Category: Legislation, Pharmaceuticals

The Campaign for Sustainable Rx Pricing, which is made up of groups from across the health care spectrum – including FAH, sent a letter to House leaders this week urging them to consider the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.

Read More »

ICYMI: FAH/AHA Drug Pricing Study Continues to Make Headlines

January 11, 2017 | FAH Policy Blog Team

Category: FAH News, Media, Pharmaceuticals

The website Healthcare Dive recently refocused the spotlight on the FAH/AHA hospital drug pricing study by publishing a feature article entitled, “How hospitals can fight the cost of budget-busting drugs.”

Read More »